GNRH1 and ovarian hyperstimulation syndrome: Use of these modified stimulation protocols (gonadotropin releasing hormone (GnRH) antagonists, GnRH agonist trigger, cryopreserving embryos, etc.)will reduce risk, but do not eliminate OHSS cases in women undergoing gonadotropin stimulation [12] or in rare cases of spontaneous OHSS during pregnancy [13].